ELISpot and FluoroSpot Assay Companies

Mabtech (Sweden) Launched the Human IL-21 analyte in two colors in its FluoroSpot Flex platform, expanding its cytokine detection capabilities.Introduced ELISpot kits in a 100-plate format and pre-coated plates to save time and reduce assay variability.

Cellular Technology Limited (CTL) (US) Launched ImmunoSpot kits containing pre-coating quality controlled (PCQC) plates, adding an essential audit trail to ELISPOT analysis.Received ISO 13485 certification for its manufacturing facility, strengthening its commitment to quality standards.

Oxford Immunotec USA, Inc. (Subsidiary of Revvity Inc.) (UK) Expanded its global distribution network for its T-SPOT.TB test for the diagnosis of latent tuberculosis infection.Announced a collaboration with the Bill & Melinda Gates Foundation to improve access to its T-SPOT.TB test in low- and middle-income countries.

Abcam plc. (UK) Launched a series of new ELISpot kits for studying immune responses to COVID-19 vaccines and other infectious diseases.Partnered with academic institutions to develop and commercialize innovative ELISpot and FluoroSpot assay applications.

List of ELISpot and FluoroSpot Assay Key Companies in the Market

• Oxford Immunotec (UK)


• Cellular Technologies (US)


• Mabtech (Sweden)


• Becton


• Dickinson and Company (US)


• and Abcam (UK)Bio-Techne (US)


• Autoimmun Diagnostika (Germany)


• Biotech Investissement (France)


• Lophius Biosciences (Germany)


• U-CyTech (Netherlands)